AI reads CT scans to outsmart pancreatic disease — fewer unnecessary surgeries ahead?

NCT ID NCT07439757

Recruiting now Diagnosis Sponsor: Changhai Hospital Source: ClinicalTrials.gov ↗

First seen Mar 14, 2026 · Last updated Jun 14, 2026 · Updated 11 times

Summary

This study is testing an artificial intelligence (AI) system that uses contrast-enhanced CT scans to help doctors make better decisions about pancreatic diseases. The AI will classify patients into three groups: needing surgery or treatment, close monitoring, or routine follow-up. Researchers will compare the AI's recommendations to those of experienced doctors to see if the AI can improve accuracy, reduce missed cancers, and prevent unnecessary surgeries. The study aims to enroll 2,000 participants with suspected pancreatic disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Changhai Hospital
RECRUITING

Shanghai, 200433, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

ACUTE PANCREATITIS (AP) CHRONIC PANCREATITIS DIAGNOSE DISEASE IPMN, PANCREATIC PANCREATIC CANCER PANCREATIC CYSTIC LESIONS PANCREATIC NEUROENDOCRINE TUMOR